Jun 6, 2022 | Featured, Research News, Technology Updates
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
May 30, 2022 | Featured, Research News, Technology Updates
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
May 24, 2022 | Featured, Technology Updates
WOW, BIG NEWS!!! Dexcom Is in Talks to Acquire Device Firm Insulet was reported by Ed Hammond and Michelle F. Davis for Yahoo.com/Finance, 23 May 2022. Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in...
May 23, 2022 | Featured, Research News, Technology Updates
Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...
May 16, 2022 | Featured, Research News, Technology Updates
Dexcom Chief Tech Officer Leach discusses G7’s European launch and FDA review, expanding Dexcom One as written by Ricky Zipp for MedTechDrive.com, 10 May 2022. Dexcom’s newest continuous glucose monitoring system, called G7, was released last quarter...
May 9, 2022 | Featured, Technology Updates
Unwelcome surprise for Vertex as FDA slaps hold on phase 1/2 diabetes cell therapy study was reported by Annalee Armstrong for FierceBiotech.com, 2 May 2022. Vertex’s new diabetes cell therapy early study of VX-880 was placed on clinical hold after...